Flow

NMR in Pharma

The PIPAc Project - Innovation for Production on Demand in Pharma

 

Controlling chemical reactions with Artificial Intelligence (AI)

The companies NovAliX, Alysophil, De Dietrich Process Systems and Bruker have joined forces to bring to market a new approach to active pharmaceutical ingredient (API) production. The partnership will leverage its complementary skills to provide a complete, standalone, and location-independent API manufacturing solution to a pharmaceutical company or contract manufacturing organization.

We interviewed each of the partners to learn more about this innovative project.

 

PIPAc project overview video

 

 

Interview Julien Marin, Director Research Services Novalix

Interview Julien Marin, Director Research Services Novalix, Strasbourg, France

 

 

Interview Philippe Robin, President Alysophil SAS

Interview Philippe Robin, President Alysophil SAS, Strasbourg, France

 

 

Interview Luis Carrillo, Managing Director DeDietrich Pharma & Green Solutions

Interview Luis Carrillo, Managing Director DeDietrich Pharma & Green Solutions, Strasbourg, France

 

 

Interview Anna Codina, Director Pharmaceutical Business Unit, Bruker BioSpin

Interview Anna Codina, Director Pharmaceutical Business Unit, Bruker BioSpin, Ettlingen, Germany